These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15353829)

  • 21. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.
    Cheng TO
    Circulation; 2004 Jul; 110(3):e23; author reply e23. PubMed ID: 15262858
    [No Abstract]   [Full Text] [Related]  

  • 22. Serial septal branch assessment in hypertrophic obstructive cardiomyopathy: New echocardiographic contrast agent for alcohol septal ablation.
    Rigopoulos AG; Pfeiffer B; Seggewiss H
    Herz; 2014 Mar; 39(2):219-21. PubMed ID: 23588605
    [No Abstract]   [Full Text] [Related]  

  • 23. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
    Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: clinicopathological correlations.
    Arrazaghi AA; Butany JW; Williams WG; Wigle DE; Rakowski H
    Can J Cardiol; 2001 Feb; 17(2):197-202. PubMed ID: 11223490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic rounds series II: hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy.
    Kern MJ; Rajjoub H; Bach R
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):221-8. PubMed ID: 10376511
    [No Abstract]   [Full Text] [Related]  

  • 26. Choice of Septal Reduction Therapies and Alcohol Septal Ablation.
    Fifer MA
    Cardiol Clin; 2019 Feb; 37(1):83-93. PubMed ID: 30447719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy.
    Wu KC; Heldman AW; Brinker JA; Hare JM; Lima JA
    Circulation; 2001 Oct; 104(15):1868. PubMed ID: 11591628
    [No Abstract]   [Full Text] [Related]  

  • 28. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior infarction following alcohol septal ablation: a consequence of "collateral damage"?
    Chowdhary S; Galiwango P; Woo A; Schwartz L
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):236-42. PubMed ID: 17195204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines.
    Maron BJ
    Prog Cardiovasc Dis; 2012; 54(6):523-8. PubMed ID: 22687595
    [No Abstract]   [Full Text] [Related]  

  • 32. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
    [No Abstract]   [Full Text] [Related]  

  • 33. Contrast echocardiography during alcohol septal ablation: friend or foe?
    Alfonso F; Isla LP; Seggewiss H
    Heart; 2005 Feb; 91(2):e18. PubMed ID: 15657208
    [No Abstract]   [Full Text] [Related]  

  • 34. Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.
    Rigopoulos AG; Seggewiss H
    Curr Cardiol Rev; 2016; 12(4):285-296. PubMed ID: 25563291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 36. Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation.
    van der Lee C; Scholzel B; ten Berg JM; Geleijnse ML; Idzerda HH; van Domburg RT; Vletter WB; Serruys PW; ten Cate FJ
    Am J Cardiol; 2008 May; 101(9):1315-20. PubMed ID: 18435964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bubble Contrast Echocardiography for Alcohol Septal Ablation.
    Arias EA; Peña-Duque MA; Martínez-Ríos MA
    Rev Esp Cardiol (Engl Ed); 2019 May; 72(5):416. PubMed ID: 29784547
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Baggish AL; Smith RN; Palacios I; Vlahakes GJ; Yoerger DM; Picard MH; Lowry PA; Jang IK; Fifer MA
    Heart; 2006 Dec; 92(12):1773-8. PubMed ID: 16807273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiography-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Hsieh TC; Patel K
    Anesth Analg; 2011 Jul; 113(1):44-6. PubMed ID: 21519056
    [No Abstract]   [Full Text] [Related]  

  • 40. Percutaneous transseptal myocardial ablation with wire (PTSAW): a new technique.
    Trehan V; Mukhopadhyay S; Rangasetty UC
    J Invasive Cardiol; 2004 Apr; 16(4):204-6. PubMed ID: 15152148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.